Group items tagged

The Indian government has suspended manufacturing in over 40 pharmaceutical companies based on a risk-based assessment conducted earlier in the year across 162 firms, according to the data provided by Union Health Minister Mansukh Mandaviya in Parliament on Thursday (Aug. 10). "Overall, a sum of 143 show-cause notices has been issued," Mandaviya said. There have been numerous recent incidents involving accusations from foreign countries regarding the contamination of syrups, eye drops, and ointments manufactured in India. Countries such as the Gambia, Uzbekistan, and Cameroon have linked the deaths of 70, 18, and six children, respectively, to cough syrups contaminated in India. Licenses for specific products have been either temporarily suspended or fully revoked for an additional 66 companies. In one case, an FIR has been registered, and in 21 cases, warning letters have been issued following inspections by both the Central Drugs Standard Control Organization and State authorities, the Minister added. Meanwhile, the Indian government has mandated rigorous testing for cough syrups before export. Starting June 1, any cough syrup must possess a government laboratory-issued certificate of analysis before being exported, the government said in a notice dated May 22.

The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a consultation on the reclassification of codeine linctus to a prescription-only medicine after considering multiple Yellow Card reports for its opioid effects, rather than for its intended use as a cough suppressant. This medication is currently licensed as a pharmacy medicine, which means that it is available to purchase over the counter in pharmacies. If reclassified as a prescription-only medicine, all strengths of codeine linctus will only be available upon presentation of a prescription. Dr Alison Cave, MHRA Chief Safety Officer, said: "Codeine linctus is an effective medicine, but as it is an opioid, its misuse and abuse can have major health consequences. Every response received will help us to develop a broader view on whether codeine linctus should be restricted to prescription-only status. We want to hear from members of the public, health professionals and others who would be affected by this potential change so we can make a properly considered decision for the benefit of patients, carers, and healthcare professionals across the UK.

Are you interested in a career helping others improve their overall health and wellbeing through nutrition? Becoming a nutritionist is an excellent way to make a positive impact on the lives of your patients. Nutritionists are experts in understanding how food affects our bodies, so they can provide advice on healthy eating habits, dietary requirements for certain medical conditions, and more. However, it takes more than just interest to become a successful nutritionist - there are specific qualifications and experience that you need to have before you can practice as one. In this blog post, we will look at what it entails so that you can start planning your journey toward becoming a certified professional nutritionist. We'll cover the education needed for certification, any licensing or registration requirements necessary for practicing in different states or countries, what kind of skillset potential employers might be looking for when hiring nutritional professionals, and finally some tips on gaining practical experience while working towards full accreditation. So if you are serious about becoming a nutritionist, let's get started! FORMAL EDUCATION REQUIREMENTS The first step towards becoming a certified professional nutritionist is often completing an accredited program in either dietetics or nutrition. A Bachelor's degree in Nutrition Science, Food Science, and Human Nutrition or Dietetics would be the minimum qualification for entry-level positions as a nutritionist. However, there are many advanced courses available that can take you further in this field such as Master of Nutrition programs and postgraduate degrees.

The Medicines and Healthcare products Regulatory Agency (MHRA) and the Committees of Advertising Practice (CAP) have issued a joint enforcement notice about the 'illegal' advertising of Kenalog injections on digital platforms. The notice warns all organisations offering Kenalog as a 'hay fever treatment' to stop advertising it in any of their social media or website advertising. "Kenalog is a prescription-only medicine (POM), which must not be directly or indirectly advertised to the public. Kenalog is not licensed for the treatment of hay fever in the UK, although it is offered by some beauty and aesthetics clinics, under the personal responsibility of an individual prescriber, and advertised widely on social media," said MHRA. "Now, advertisers must ensure that all references to Kenalog in the text, images or emojis on social media are removed, as well as commonly-used descriptive phrases for the jab such as 'hay fever injection' or hay fever jab' or any account names, testimonials or memes by 29 August 2022." After this date, the CAP's compliance team will remove non-compliant ads using targeted software and those who continue to promote it may be referred to the MHRA for further enforcement action.

Rosemont Pharmaceuticals (Rosemont) has acquired Lucis Pharma Ltd, a specialist pharmaceutical business in the UK. Through this acquisition Rosemont will expand its existing portfolio and have access to a pipeline of innovative products, providing lifesaving pharmaceuticals to the UK and overseas markets. Founded in 2012, Lucis has grown to become a leading provider in the development and licensing of novel and exclusive medicines. With over a dozen SKUs covering a variety of therapeutic areas, Lucis has established a strong portfolio that, in addition to a pipeline of innovative developments, serve the growing patient need for liquid medicines. The acquisition will enable Rosemont to broaden its portfolio and enter the unit dose / sachet market through the pipeline products, whilst growing the business through recent Lucis product launches in 2021/22. "As well as continuing to broaden our portfolio and add to our strong growth globally, this acquisition also gives access to pipeline products and developer relationships to accelerate our entry into new product areas such as sachets" said Howard Taylor, Chief Executive Officer of Rosemont.

The UK must act swiftly to fend off competition if it wants to build the world's leading life sciences sciences hub, a new report suggests. A year on from the launch of the government's life science vision, the report commissioned by the the Association of the British Pharmaceutical Industry said although achieving the ambition remained feasible, the UK would need an attractive business environment because its competitor countries were becoming more adept at attracting investment. To achieve the ambition of the vision, the PwC-produced report suggested raising pharmaceutical R&D investment in the UK to build a 'stronger manufacturing and research infrastructure', alongside better investment in, access to and uptake of innovative medicines. It said the UK would also need to adopt a renewed approach to the priority healthcare challenges identified in the government's 'Life Science Vision', which would mean cutting the overall burden on health of dementia, cancer, cardiovascular and respiratory disease and mental health. The report quantified the size of the prize if the vision was implemented in full and the UK could emulate the successes of leading EU countries, which included: £68 billion in additional GDP over 30 years, owing to increased R&D investment £16.3 billion additional annual GDP from increased pharmaceutical exports Supporting 85,000 additional jobs Up to 40 per cent decrease in disease burden across the whole UK - for areas like cardiovascular disease, mental health conditions and Cancer. Reduced variation in speed of access to new medicines within three months of licensing for all NHS patients.

New data released on Friday (July 1) shows how public support has continued to grow despite a lack of progress on the policy front, 15 years since a smokefree legislation in Britain prohibited smoking inside public spaces such as offices, shops and pubs. This was demonstrated by a new report 'Fifteen Smokefree Years' summarising results from the annual survey carried out since 2007 by YouGov for the public health charity Action on Smoking and Health. Around three quarters (74 per cent) of those who participated in survey supported the government's Smokefree 2030 ambition. The report said: "The public are way ahead of the government, and right behind recommendations made to the Health and Social Care Secretary for the forthcoming Tobacco Control Plan by Javed Khan's independent review." Three quarters (76 per cent) support making tobacco manufacturers pay a levy to fund tobacco control and smoking cessation, 83 per cent support requiring retailers to be licensed to sell tobacco, 70 per cent support increased investment in public education campaigns, 67 per cent support warnings on cigarettes, and 62 per cent support making seating areas outside restaurants, pubs and cafes smokefree.

The Medicines and Healthcare Products Regulatory Agency (MHRA) confirmed that Ozempic has been found at two UK wholesalers on 18 October. The pre-filled falsely labelled pens have been purchased from legitimate suppliers in Austria and Germany. However, there has been no evidence that fake Ozempic has been supplied to UK patients. Dr Alison Cave, MHRA Chief Safety Officer spoke about closely with regulatory partners to ensure patients' safety. He said: "Buying semaglutide from illegally trading online suppliers significantly increases the risk of getting a product either falsified or not licensed for use in the UK. "Products purchased in this way will not meet our strict quality and safety standards, and taking such medicines may put your health at risk," he added.

The Medicines and Healthcare products Regulatory Agency (MHRA) has warned the public to avoid buying pre-filled weight loss pens without a prescription. The warning came after 369 fake Ozempic injections have been seized since January 2023. However, Saxenda pens were obtained by members of the public in the UK through "non-legitimate routes". The health regulator has urged the public to buy the pens after consulting a healthcare professional and with a prescription. Dr Alison Cave, MHRA Chief Safety Officer shared her opinion on the matter, she said: "Buying products such as Ozempic or Saxenda without a prescription, from illegally trading suppliers, significantly increases the risk of receiving something which is either fake or not licensed for use in the UK.

Travelling with medical cannabis can be a complex and often confusing experience, given the diverse legal regulations across different countries and states. Patients who rely on medical cannabis for their wellbeing need to be well-informed and prepared to ensure a smooth and hassle-free travel experience. This comprehensive guide covers essential aspects, legal considerations, and practical tips for individuals who use medical cannabis and wish to travel. Know the Laws The first and most crucial step before travelling with medical cannabis is to understand the laws and regulations of both the departure and destination locations. Laws regarding medical cannabis use vary significantly from one country, state, or even city to another. Some places have legalised medical cannabis, while others strictly prohibit its use. Researching and familiarising oneself with the specific regulations of the destination, transit countries, and the home country is essential. Travelling Within the Same Country When travelling within a country where medical cannabis is legal, patients generally need to carry their prescription information issued by a licensed healthcare provider. It's advisable to keep medical cannabis in its original packaging, clearly labelled with the patient's name, prescribing physician, and dosage instructions. Carrying a copy of the relevant laws and regulations can also be helpful in case of any inquiries from authorities. What can be easier than carrying around paperwork, which could get easily damaged or lost during your travels, is to get a medical card that has a unique QR code on it from Releaf Cannabis, which, when scanned, can present their prescription information digitally - it has revolutionised the way patients manage their healthcare. This eliminates the need for physical documents and streamlines the process but also ensures the security and confidentiality of sensitive medical information, offering patients a more efficient and organi

The Medicines and Healthcare Products Regulatory Agency (MHRA) has authorised an innovative and first-of-its-kind gene-editing treatment for sickle-cell disease and transfusion-dependent β-thalassemia. Known as Casgevy (exagamglogene autotemcel), the treatment is based on the innovative gene-editing tool CRISPR, for which its inventors were awarded the Nobel Prize in 2020. Casgevy is the first medicine to be licensed that uses CRISPR, and it is to be used for treating patients aged 12 and over. To date, a bone marrow transplant has been the only permanent treatment option for these life-long conditions, which in some cases can be fatal. The MHRA's authorisation came after a rigorous assessment of its safety, quality and effectiveness.

American biotechnology company Novavax said on Monday (February 28) it would pursue full approval of its Covid-19 vaccine in the second half of this year and forecast total revenue of between $4 billion and $5 billion for 2022. "We expect to gain additional authorizations where we have already filed, including in the US. We will pursue full approval of our vaccine including filing our BLA (biologics license application), in the second half of 2022," CEO Stanley Erck said during a post-earnings call. Novavax late last month filed for emergency use authorization of the shot in U.S. adults, a much-awaited step following months of struggles with development and manufacturing problems. Novavax said it has completed delivery of around nine million vaccine doses to Indonesia, 6 million to Australia and two million to South Korea and expects to supply 69 million doses to Europe in the first half of this year.

The modern-day alchemist is a pharmacist, unbeknownst to many. This career path has long been associated with science and chemistry, but the role of pharmacists today is much more than just preparing potions or drugs. If you have an interest in the science of medicine, and a desire to help people better manage their health, becoming a pharmacist could be the perfect career choice for you. In this article, we'll discuss what it takes to become a pharmacist, as well as the rewards that come along with the job. 1. ASSESS EDUCATIONAL REQUIREMENTS Since a career as a pharmacist requires post-secondary education, the first step in becoming a qualified pharmacist is to assess the educational requirements. This includes researching what courses are necessary, at what level of education they must be taken, and which universities offer these courses. And, as pharmacists must be licensed before they can legally practice, prospective professionals should also research the regulations associated with becoming a pharmacist. 2. CHOOSE A PHARMACY SCHOOL When deciding which pharmacy school to attend, it is important to consider the school's curriculum, accreditation, and reputation. Researching schools that have strong faculty and offer internships is also an important consideration. Also, have in mind that whether you want to know how to become a pharmacy tech in California for instance, or anywhere else for that matter, you can find useful information on the internet. As a rule of thumb, as an aspiring pharmacist, you should aim to attend an accredited school that offers specialized courses in pharmacology, toxicology, biochemistry, and other related areas.

There are a lot of different beauty procedures that you can try in order to achieve healthy-looking skin. It's essential to consult with a dermatologist or other skin care professional to find out which procedures will work best for you, depending on your skin type and concerns. This article will briefly describe some of the different procedures that are available. Here are some contemporary beauty procedures to consider. 1. SKIN NEEDLING Skin needling, also known as micro-needling, is a minimally invasive procedure that can be used to improve the overall appearance of your skin. It involves using a device with fine needles to create tiny punctures on the skin's surface. Additionally, the effects of skin needling can last long after the initial treatment, making it a popular choice for those looking for a more lasting solution. This helps to stimulate collagen production and can reduce the appearance of wrinkles, fine lines, scarring, and other skin imperfections. Skin needling can be done independently or with other treatments such as radiofrequency therapy or chemical peels. It's important to note that skin needling should only be performed by a licensed professional. 2. RADIOFREQUENCY THERAPY If you're unhappy with the way your skin looks, it may be time to consider a radiofrequency therapy treatment. Radiofrequency therapy uses electromagnetic waves to heat up the deeper layers of your skin, stimulating collagen production and improving blood circulation. This can help to improve the appearance of wrinkles, fine lines, and sagging skin. Additionally, radiofrequency therapy can also help to improve the appearance of cellulite and stretch marks. It's a relatively safe and non-invasive procedure, and there is little to no downtime.

thx for sharing! i would like to use that

That is good option indeed but I guess with a complex training and suggestions u can temporally get rid of that( here for more info https://betterme.world/articles/does-cellulite-go-away/ ). While there is no guaranteed way to completely eliminate cellulite, there are various methods that can help reduce its appearance. Here are some options: Exercise: Regular exercise can help strengthen and tone muscles, reducing the appearance of cellulite. Healthy diet: Eating a healthy, balanced diet can help reduce the appearance of cellulite. Massage: Massaging the areas with cellulite may help improve circulation and reduce its appearance. Topical treatments: Creams and lotions containing caffeine, retinol, or antioxidants may help reduce the appearance of cellulite. Medical procedures: More invasive procedures such as laser therapy, radiofrequency treatments, and liposuction may also be options for reducing cellulite, but they can be expensive and may come with risks. It's important to remember that cellulite is a natural part of the body and many people have it, regardless of their weight or fitness level. While these methods may help reduce its appearance, it may not completely go away.

The Department of Health and Social Care (DHSC) has issued an alert to update healthcare professionals on the shortage of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which are used to treat type 2 diabetes. It has informed that the supply of the drugs continues to be limited, and is not expected to return to normal until at least the end of 2024. An increase in demand for these products for licensed and off-label indications is cited as the cause of the supply issues. "Rybelsus® (semaglutide) tablets are now available in sufficient quantities to support initiation of GLP1 RA treatment in people with type 2 diabetes (T2DM) in whom new initiation of GLP-1 RA therapy would be clinically appropriate," the DHSC's National Patient Safety Alert reads.

The Royal Pharmaceutical Society (RPS) has appointed Dr Amira Guirguis as the new Chair of its Science and Research Committee, effective from the New Year. An accomplished pharmacist and renowned expert in substance misuse, Dr Guirguis was nominated by the RPS as a 'woman to watch' in 2020. Previously, she has served as the Principal Investigator for the first Home Office-licensed Pharmacist-led drug checking service in the UK, and as the MPharm Programme Director at Swansea University Medical School. A PhD in Novel Psychoactive Substances (NPS) detection, she has made significant contributions to the field of pharmacy, to drug policy, and has won the 2014 JPAG Geoffrey Phillips award for her groundbreaking research.

The site is licensed by the Health Advertisement Department of Ministry of Health under No. 2940/2/11/10/11/13 © 2012 Atlas Spinal Center. All rights reserved.

Call today for guaranteed relief and results! Massage Revolution Wellness Center 310-798-4263 Family Owned Business Licensed and Professional Neuromuscular Massage Therapists Massage Revolution & Therapeutic Massage Los Angeles offers all types of massage services to help you live relaxed, rejuvenated, and pain-free.

Health Level Seven International (HL7), one of the leaders in developing interoperability standards for healthcare IT has announced its decision to make much of its intellectual property (IP), includes standards, freely available under licensing terms. The landmark decision represents HL7's commitment to the betterment of healthcare worldwide by ensuring that all stakeholders have equal access to its HIT standards. The new policy is expected to take effect in the first quarter of 2013.

fat loss diets in http://fatlossdietss.com